| Code | 9551E | ||||||||||
| MA number | 59/0123/25-S | ||||||||||
| Product Form: | cps end 56x240 mg (blis. Al/PVC/PVDC) | ||||||||||
| MA Status: | R - Valid Marketing Authorisation | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | Sandoz Pharmaceuticals d.d., Slovenia | ||||||||||
| Therapeutic Class: | 59 - IMMUNOPRAEPARATA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Container: | blister Al/PVC/PVDC | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to restricted medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 08.05.2025 |
| Validity: | 08.05.2030 |
| Pediatric indication: | Yes |
| Pediatric posology: | Yes |
| SPC: |
SPC_Dimetyl-fumarát Sandoz 120 mg, 240 mg_cps end_04/2025_REG.pdf
|
| PIL: |
PIL_Dimetyl-fumarát Sandoz 120 mg, 240 mg_cps end_04/2025_REG.pdf
|
| Safety feature | Yes |
| Data update: | 20.05.2025 |
